podophyllin has been researched along with Lung-Neoplasms* in 16 studies
16 other study(ies) available for podophyllin and Lung-Neoplasms
Article | Year |
---|---|
β-Apopicropodophyllin functions as a radiosensitizer targeting ER stress in non-small cell lung cancer.
In this study, we examined whether β-apopicropodophyllin (APP) could act as a radiosensitizer in non-small cell lung cancer (NSCLC) cells.. The in vitro radiosensitizing activity of APP was demonstrated with clonogenic assay, immunoblotting, Annexin V-Propidium iodide (PI) assay, BrdU incorporation, detection of mitochondrial ROS/intracellular of H. The results of a clonogenic assay indicated that a combination of APP and γ-ionizing radiation (IR) inhibits cell growth and increases cell death in NSCLC cells. Several signal transduction pathways were examined for their potential involvement in the apparent radiosensitization effect of APP, as assessed by immunoblotting analyses and mitochondrial potential determination in vitro. Treatment of NCI-H460 cells with 15 nM APP and NCI-H1299 cells with 10 nM APP yielded dose-enhancement ratios of 1.44 and 1.24, respectively. Enhanced ER stress, disrupted mitochondrial membrane potential, and increased reactive oxygen species (ROS) were observed in cells co-treated with APP and IR, and this was followed by the cytosolic release of cytochrome c and consequent activation of caspase-3 and -9. Notably, inhibition of JNK, which prevents caspase activation, blocked the APP/IR-induced activations of ER stress and apoptotic cell death. In NCI-H460 or NCI-H1299 cell-xenografted mice, APP/IR treatment delayed the time it took tumors to reach a threshold size by 22.38 and 16.83 days, respectively, compared with controls, to yield enhancement factors of 1.53 and 1.38, respectively.. APP has a radiosensitizing function derived from its ability to induce apoptotic cell death via activation of ER stress, disruption of mitochondrial membrane potential, and induction of the caspase pathway. Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Endoplasmic Reticulum Stress; Humans; Hydrogen Peroxide; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Podophyllin; Radiation-Sensitizing Agents; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2019 |
Characterization of rabbit SP-B promoter region responsive to downregulation by tumor necrosis factor-alpha.
Surfactant protein B (SP-B) is essential for the maintenance of biophysical properties and physiological function of pulmonary surfactant. Tumor necrosis factor-alpha (TNF-alpha), an important mediator of lung inflammation, inhibits surfactant phospholipid and surfactant protein synthesis in the lung. In the present study, we investigated the TNF-alpha inhibition of rabbit SP-B promoter activity in a human lung adenocarcinoma cell line (NCI-H441). Deletion experiments indicated that the TNF-alpha response elements are located within -236 bp of SP-B 5'-flanking DNA. The TNF-alpha response region contained binding sites for nuclear factor-kappa B (NF-kappa B), Sp1/Sp3, thyroid transcription factor (TTF)-1, and hepatocyte nuclear factor (HNF)-3 transcription factors. Inhibitors of NF-kappa B activation such as dexamethasone and N-tosyl-L-phenylalanine chloromethyl ketone and mutation of the NF-kappa B element did not reverse TNF-alpha inhibition of SP-B promoter, indicating that TNF-alpha inhibition of SP-B promoter activity occurs independently of NF-kappa B activation. TNF-alpha treatment decreased the binding activities of TTF-1 and HNF-3 elements without altering the nuclear levels of TTF-1 and HNF-3 alpha proteins. Pretreatment of cells with okadaic acid reversed TNF-alpha inhibition of SP-B promoter activity. Taken together these data indicated that in NCI-H441 cells 1) TNF-alpha inhibition of SP-B promoter activity may be caused by decreased binding activities of TTF-1 and HNF-3 elements, 2) the decreased binding activities of TTF-1 and HNF-3 alpha are not due to decreased nuclear levels of the proteins, and 3) okadaic acid-sensitive phosphatases may be involved in mediating TNF-alpha inhibition of SP-B promoter activity. Topics: Adenocarcinoma; Animals; Cell Line; Cell Nucleus; Cytosol; DNA-Binding Proteins; Gene Expression Regulation; Hepatocyte Nuclear Factor 3-alpha; Humans; Lung Neoplasms; Mutagenesis, Site-Directed; NF-kappa B; Nuclear Proteins; Podophyllin; Podophyllotoxin; Promoter Regions, Genetic; Proteolipids; Pulmonary Surfactants; Rabbits; Thyroid Nuclear Factor 1; Transcription Factors; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
[Levels of tumor markers (orosomucoid, pregnancy-associated alpha 2-glycoprotein, pregnancy protein-1, placental specific-tissue protein 10, placental specific-tissue protein 12, alpha 1-fetoprotein) in the serum of patients with bronchial carcinoma].
Concentration of orosomucoid, pregnancy associated alpha 2-glycoprotein (alpha 2-PAG), Schwangerschaftsprotein 1 (SP1), placental specific-tissue protein 10 (PP10), placental specific-tissue protein 12 (PP12), alpha 1-Fetoprotein (AFP) were estimated in serum samples of 83 patients with lung cancer of stages II-IV. The proteins were determined by means of the single radial immunodiffusion, the rocket immunoelectrophoresis, the radioimmunoassay and the enzymeimmunoassay. Orosomucoid, PP12 and AFP serum concentrations of the cancer group compared with those of the control group, were increased significantly. Orosomucoid (control group: means = 0.828 g/l; s = 0.301; tumour group: mean = 2.16 g/l; s = 0.862); PP12 (control group: mean = 54.08 micrograms/l; s = 61.70; tumour group: mean = 122.52 micrograms/l; s = 131.16); AFP (control group: mean = 3.05 micrograms/l; s = 3.76; Tumour group: means = 8.29 micrograms/l; s = 17.75). alpha 2-PAG was found only in 37 cases of the tumour group; SP1 in 22 cases. PP10 (control group: mean = 2.25 micrograms/l; s = 0.866; tumour group: mean = 2.503 micrograms/l, s = 1.508). On condition that 2 tested parameters at least were estimated in the pathological range the sensitivity amounted to 0.64 and the specificity to 0.92. Topics: Aged; alpha-Fetoproteins; Carcinoma, Bronchogenic; Female; Glycoproteins; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Lung Neoplasms; Male; Middle Aged; Orosomucoid; Podophyllin; Podophyllotoxin; Pregnancy Proteins | 1986 |
[Combined low-dose radiation and adriblastin therapy of lung metastases].
Two patients with lung metastases are presented who were submitted to a combined low-dose radiotherapy and adriamycin monotherapy with good palliative results. The mode of action as well as the experimental examination results are discussed. The ineffectiveness of single low-dose chemotherapy is demonstrated by the non-response of lung metastases beyond the irradiation fields (heart block, diaphragm). Both patients were resistant to chemotherapy. Topics: Adenocarcinoma; Aged; Carcinoma; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Hysterectomy; Lung Neoplasms; Male; Methotrexate; Middle Aged; Podophyllin; Podophyllotoxin; Radioisotope Teletherapy; Uterine Neoplasms | 1985 |
[Therapy of osteodystrophia deformans (Paget's disease)].
Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Calcinosis; Calcitonin; Cholecalciferol; Cyclophosphamide; Ergocalciferols; Fractures, Spontaneous; Humans; Hypercalcemia; Kidney Calculi; Lung Neoplasms; Male; Neoplasm Metastasis; Osteitis Deformans; Plicamycin; Podophyllin; Quinones; Sarcoma; Vitamin D | 1974 |
Local therapy of malignant pleural effusions.
Topics: Animals; Breast Neoplasms; Bronchial Neoplasms; Cattle; Cyclophosphamide; Drug Combinations; Female; Glucose; Gold Isotopes; Humans; Hydrazines; L-Lactate Dehydrogenase; Lactates; Lung Neoplasms; Male; Mannitol; Muramidase; Neoplasm Metastasis; Pancreatic Extracts; Papain; Plant Extracts; Pleural Effusion; Pleural Neoplasms; Podophyllin; Proteins; Radioisotopes; Thymus Extracts; Time Factors | 1974 |
[Proresid in the treatment of lung cancer].
Topics: Adult; Aged; Antineoplastic Agents; Evaluation Studies as Topic; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllin; Time Factors | 1971 |
[On diagnostic and therapeutic problems of the metastasizing breast carcinoma].
Topics: Adult; Aged; Austria; Breast Neoplasms; Diagnosis, Differential; Gold Colloid, Radioactive; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Plants, Medicinal; Plants, Toxic; Pleural Effusion; Pleural Neoplasms; Podophyllin; Podophyllum | 1969 |
[Antineoplastic polychemotherapy in thoracic pathology].
Topics: Adrenalectomy; Aged; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Cortisone; Cyclophosphamide; Drug Synergism; Ethinyl Estradiol; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Hydrazines; Hypophysectomy; Kidney Neoplasms; Lung Neoplasms; Male; Melanoma; Melphalan; Mesothelioma; Methotrexate; Middle Aged; Nandrolone; Neoplasm Metastasis; Ovarian Neoplasms; Podophyllin; Sarcoma; Thiotepa; Vinblastine | 1968 |
[Clinical findings in podophyllotoxin derivatives (SP-I-SP-G) in malignant tumors].
Topics: Adult; Aged; Animals; Antineoplastic Agents; Female; Humans; Leukemia, Myeloid; Lung Neoplasms; Male; Middle Aged; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Stomach Neoplasms | 1968 |
[Anticancer chemotherapy with evaluation of combined treatments].
Topics: Adolescent; Adult; Aged; Alkylating Agents; Amides; Antibiotics, Antineoplastic; Antineoplastic Agents; Aziridines; Azirines; Drug Synergism; Fluorouracil; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Middle Aged; Mitomycins; Phosphinic Acids; Podophyllin; Prednisolone | 1968 |
[The effect of Proresid on the growth and formation of metastases of the RBI-sarcoma in rats].
Topics: Animals; Antineoplastic Agents; Lung Neoplasms; Mitosis; Neoplasm Metastasis; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Rats; Sarcoma, Experimental | 1968 |
[Observations on the therapy of primary cancer of the lung (sample research on 100 subjects treated)].
Topics: Antineoplastic Agents; Cyclophosphamide; Female; Humans; Lung Neoplasms; Male; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum | 1967 |
[Cytostatic chemotherapy in the treatment of malignant tumors].
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Hematopoiesis; Humans; Kidney Neoplasms; Leukopenia; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasms; Podophyllin; Rectal Neoplasms; Triaziquone | 1966 |
[Experience with podophyllin derivatives in the treatment of lung tumors].
Topics: Antineoplastic Agents; Humans; Lung Neoplasms; Podophyllin | 1966 |
[Cancerogenic and other side-effects of podophyllin and nitrogen mustards].
Topics: Animals; Liver Neoplasms; Lung Neoplasms; Mechlorethamine; Neoplasms, Experimental; Nitrogen Mustard Compounds; Podophyllin; Sarcoma, Experimental | 1953 |